Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5, Cell Death Differ, vol.15, issue.5, pp.751-61, 2008. ,
Death receptors: signaling and modulation, Science, vol.281, issue.5381, pp.1305-1313, 1998. ,
Synthetic ligands of death receptor 5 display a cellselective agonistic effect at different oligomerization levels, Oncotarget, vol.7, issue.40, pp.64942-64956, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02185410
Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity, J. Biol. Chem, vol.275, issue.40, pp.31171-31178, 2000. ,
Molecular recognition by a binary code, J. Mol. Biol, vol.348, issue.5, pp.1153-62, 2005. ,
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity, Cancer Cell, vol.26, issue.2, pp.177-89, 2014. ,
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5, Mol. Cell, vol.4, issue.4, pp.563-71, 1999. ,
Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antiobody agonists, J. Mol. Biol, vol.361, issue.3, pp.522-558, 2006. ,
, , 1997.
, Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL, J. Biol. Chem, vol.272, issue.41, pp.25417-25437
TRAIL in cancer therapy: present and future challenges, Expert Opin Ther Targets, vol.11, issue.10, pp.1299-1333, 2007. ,
Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation, Nat. Struct. Biol, vol.6, issue.11, pp.1048-53, 1999. ,
Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions, PloS Pathog, vol.9, issue.3, p.1003224, 2013. ,
Is TRAIL the holy grail of cancer therapy, Apoptosis, vol.14, issue.4, pp.607-630, 2009. ,
Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity, Cancer Res, vol.70, issue.3, pp.1101-1111, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00451170
Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation, Chembiochem, vol.16, issue.2, pp.293-301, 2015. ,
Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients, Prog. NMR Spectr, vol.34, pp.93-158, 1999. ,
CcpNmr Analysis assign: a flexible platform for integrated NMR analysis, J. Biomol. NMR, vol.66, pp.111-124, 2016. ,
Targeting death-inducing receptors in cancer therapy, Oncogene, vol.26, issue.25, pp.3745-57, 2007. ,
, , 2015.
, Human Monoclobal Agonistic Antibody KMTR2. Sci Rep, vol.5, p.17936
TALOS-N : Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks, J. Biomol. NMR, vol.56, pp.227-241, 2013. ,
TRAIL-R2: a novel apoptosismediating receptor for TRAIL, EMBO J, vol.16, issue.17, pp.5386-5393, 1997. ,
Probability-based protein secondary structure identification using combined NMR chemical-shift data, Protein Sci, vol.11, issue.4, pp.852-61, 2002. ,
,
, 13C and 15N chemical shift referencing in biomolecular NMR, 1H, vol.6, pp.135-175